Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency recommends conditional approval of Pixuvri (pixantrone) for relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma 17 Februar 2012Press releaseHumanMedicines European Medicines Agency recommends new anti-malaria treatment for use outside the European Union 17 Februar 2012Press releaseHumanMedicines European Medicines Agency concludes review of dose recommendations for anti-tuberculosis medicines used in children 17 Februar 2012Press releaseHumanMedicinesPaediatrics European Medicines Agency recommends lifting suspension of aprotinin 17 Februar 2012Press releaseHumanMedicines European Medicines Agency recommends new contraindications and warnings for aliskiren-containing medicines 17 Februar 2012Press releaseHumanMedicines European Medicines Agency gives final recommendations for 12 centrally authorised medicines manufactured at Ben Venue Laboratories 16 Februar 2012Press releaseHumanMedicines European Medicines Agency informs doctors and patients about drug interaction between Victrelis and ritonavir-boosted HIV protease inhibitors 16 Februar 2012Press releaseHumanMedicines European Medicines Agency confirms positive benefit-risk balance of orlistat-containing medicines 16 Februar 2012Press releaseHumanMedicines GlaxoSmithKline withdraws its application for an extension of the indication for Tyverb (lapatinib) 16 Februar 2012Press release Novartis Vaccines and Diagnostics S.r.l. withdraws its application for paediatric use marketing authorisation for Fluad Paediatric (influenza vaccine) 16 Februar 2012Press releasePaediatricsVaccines 1 … 259 260 261 262 263 Page 263 of 384 264 265 266 267 … 384
European Medicines Agency recommends conditional approval of Pixuvri (pixantrone) for relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma 17 Februar 2012Press releaseHumanMedicines
European Medicines Agency recommends new anti-malaria treatment for use outside the European Union 17 Februar 2012Press releaseHumanMedicines
European Medicines Agency concludes review of dose recommendations for anti-tuberculosis medicines used in children 17 Februar 2012Press releaseHumanMedicinesPaediatrics
European Medicines Agency recommends lifting suspension of aprotinin 17 Februar 2012Press releaseHumanMedicines
European Medicines Agency recommends new contraindications and warnings for aliskiren-containing medicines 17 Februar 2012Press releaseHumanMedicines
European Medicines Agency gives final recommendations for 12 centrally authorised medicines manufactured at Ben Venue Laboratories 16 Februar 2012Press releaseHumanMedicines
European Medicines Agency informs doctors and patients about drug interaction between Victrelis and ritonavir-boosted HIV protease inhibitors 16 Februar 2012Press releaseHumanMedicines
European Medicines Agency confirms positive benefit-risk balance of orlistat-containing medicines 16 Februar 2012Press releaseHumanMedicines
GlaxoSmithKline withdraws its application for an extension of the indication for Tyverb (lapatinib) 16 Februar 2012Press release
Novartis Vaccines and Diagnostics S.r.l. withdraws its application for paediatric use marketing authorisation for Fluad Paediatric (influenza vaccine) 16 Februar 2012Press releasePaediatricsVaccines